Zefylti

Zefylti (Filgrastim) is a biologic medication used to stimulate white blood cell production in the body. It supports immune function during chemotherapy or bone marrow transplant recovery. This EU-sourced injectable is designed for intravenous or subcutaneous use. Always consult a healthcare provider before use.

Filgrastim is commonly used to reduce the risk of infection in patients receiving chemotherapy that lowers white blood cells. It may also be prescribed after bone marrow transplants to speed recovery. The medication helps the body produce more neutrophils, a type of white blood cell essential for fighting infections. It is not a treatment for infections themselves but supports the immune system during vulnerable periods.

Filgrastim works by stimulating the bone marrow to produce more white blood cells, particularly neutrophils. Patients may notice improved energy levels as their immune function stabilizes. Some individuals report mild bone or muscle discomfort during treatment, which is typically temporary. Regular monitoring is recommended to assess effectiveness and adjust dosing as needed.

Store Filgrastim in the refrigerator but avoid freezing. Protect it from light and keep it in the original packaging until ready to use. Do not shake the vial or syringe vigorously, as this may damage the medication. Always check the appearance of the solution before use; discard if it appears cloudy or contains particles. Keep out of reach of children and pets.

Filgrastim may interact with other medications that affect bone marrow function, such as chemotherapy drugs. Combining it with lithium could potentially enhance its effects, so close monitoring is advised. There are no known severe interactions with common over-the-counter medications, but always inform your healthcare provider about all drugs you are taking. Alcohol use should be discussed with a doctor, as it may impact treatment efficacy.